ADSORB: a study on the efficacy of endovascular grafting in uncomplicated acute dissection of the descending aorta
- PMID: 22575291
- DOI: 10.1016/j.ejvs.2012.03.023
ADSORB: a study on the efficacy of endovascular grafting in uncomplicated acute dissection of the descending aorta
Abstract
Acute dissection of the descending thoracic aorta carries a 30-day mortality of around 10% with best medical treatment (BMT). In addition, about 25% will develop an aneurysm during the following 4-5 years. This is the first ever randomised trial on acute dissections comparing BMT with BMT and stent grafting of the proximal tear in patients having an uncomplicated acute dissection of the descending aorta. The commonly used temporal definition of acute dissection being within 14 days of onset of symptoms is applied. A total of 61 patients will be randomised and followed at regular intervals (1, 3, 6, 12, 18, 24, 30 and 36 months) after acute dissection. Thrombosis of the false lumen, aortic enlargement and rupture are the primary end points. The study will examine whether aortic remodelling occurs after stent grafting in acute type B dissections, and its effect on aneurysm formation, rupture and re-intervention.
Copyright © 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Comment in
-
ADSORB: a prospective randomised study on the efficacy of endovascular grafting vs. best medical treatment in uncomplicated acute dissection of the descending aorta.Eur J Vasc Endovasc Surg. 2012 Jul;44(1):38-9. doi: 10.1016/j.ejvs.2012.04.002. Epub 2012 Apr 22. Eur J Vasc Endovasc Surg. 2012. PMID: 22531453 No abstract available.
-
Commentary on 'ADSORB: a study on the efficacy of endovascular grafting in uncomplicated acute dissection of the descending aorta'.Eur J Vasc Endovasc Surg. 2012 Jul;44(1):37. doi: 10.1016/j.ejvs.2012.04.005. Epub 2012 Apr 29. Eur J Vasc Endovasc Surg. 2012. PMID: 22546641 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
